Now open access in NDT Obinutuzumab versus RTX for refractory primary membranous nephropathy 🧐This retrospective study suggests that OBI is an effective option for pts with prim. MGN refractory to GC+CTX, CNI, and RTX regimen. ▶️academic.oup.com/ndt/article/do……

La ville de Ville de Rouen devient ambassadrice du #dondorganes 🫶

CITATION 💕 👉 Je ne savais pas que c'était impossible alors je l'ai fait 🙏 Pas de mots pour décrire cette course 2024 avec ses chiffres démentiels 181km/11200d++ #dialyse #inclusion #dondorganes #ultraTrail

Séquencer un génome en moins de 48 heures ! acteursdesante.fr/sequencer-un-g…

Join GlomCon in its Kidney Transplantation Series this Sunday Belatacept in Kidney Transplantation: Clinical Practice by Dr. Dominique Bertrand ID: 875 5077 1266 Passcode 202122 Sign up 👉🏻 bit.ly/3zm4tYy #GlomCon

Belatacept in Kidney Transplantation Clinical Practice by Dr. Dominique Bertrand Total live participants: 110 From 46 countries Watch the session here 👉 my.glomcon.org #GlomCon

Now open access in NDT Donor-derived cfDNA monitoring for early diagnosis of AMR in kidney TX: a randomized trial 🧐Dd-cfDNA-guided biopsy in KTR with prevalent dnDSA can reduce the time to AMR diagnosis + therapy initiation. ▶️academic.oup.com/ndt/article/do…

🚨🚨🚨So happy to share our multicentric study about the risk of TCMR after belatacept rescue conversion 🛟 in a large cohort of KT recipients. Many thanks 🙏 to my friends from the ⁦Groupe Spiesser⁩ ! frontierspartnerships.org/journals/trans…

SGLT2 Inhibitor #SGLT2i in #Diabetic and #NonDiabetic Renal #Transplant Recipients #VisualAbstract by Dr P S Vali kireports.org/article/S2468-…

#Biopsy-proven #Tcell mediated #rejection after #Belatacept rescue conversion: a multicenter retrospective study bit.ly/3VAnnmn

Original Article: Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma (AQUILA) nej.md/3Zh3pOJ #ASH24 | ASH

🚨🚨🚨Published in KI Reports: Our multicenter study reveals that early thrombotic microangiopathy occurs in 6.1% of ABO-incompatible KT. 📢 Key findings highlight predictive antibody titers and treatment strategies with plasmapheresis & eculizumab. kireports.org/article/S2468-…

Early Thrombotic Microangiopathy #TMA After #ABOIncompatible Living Donor Kidney Transplantation #LDKT #VisualAbstract by Cristina Popa 🦋 kireports.org/article/S2468-…

The Transplant International Monthly Issue is here, check it out: frontierspartnerships.org/journals/trans… From Dominique Bertrand, Dominique Guerrot, Dany Anglicheau et al. Congratulations! ESOTtransplant

The next step: Passive transfer of patient-derived anti-nephrin autoantibodies causes a podocytopathy with minimal change lesions doi.org/10.1172/JCI186… By Felicitas Hengel Nicola M. Tomas Tobias B. Huber

Donor-derived EBV infection due to transplant poses a higher risk of cancer than anyone knew. Congratulations to Vishnu Potluri, Chethan Puttarajappa and their team. This research will change how we counsel EBV-negative patients. acpjournals.org/doi/10.7326/AN…

Presented at #ISNWCN: In the REGENCY trial, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, plus standard therapy provided significantly better renal responses than standard therapy alone in patients with lupus nephritis. Full trial results:

🚨BREAKING: Our report on the first-ever pig kidney xenotransplant in a living human with ESRD is now published in NEJM! A major milestone in transplantation, paving the way for a new era of organ replacement Mass General Transplant Mass General Kidneys eGenesis more: nejm.org/doi/full/10.10…

Monoclonal gammopathy of unknown significance is common, often discovered incidentally and indolent. This Review summarizes evidence on the diagnosis and management of monoclonal gammopathy of unknown significance to guide clinical decision-making. ja.ma/4k14gwi

Happy to share this study in KIReports DOAC seems to be safe in nephrotic syndrom while being more convenient than VKA 🧵 1/2 kireports.org/article/S2468-…